Suven Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 25.46 | 25.46 | 25.46 | 25.46 | 12.73 |
Reserves | 2,030.44 | 1,723.92 | 1,495.24 | 1,039.73 | 770.10 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 2,055.90 | 1,749.38 | 1,520.70 | 1,065.19 | 782.83 |
Secured Loans | 38.58 | 69.16 | 95.57 | 99.78 | 26.26 |
Unsecured Loans | 26.42 | 1.18 | 1.55 | 43.26 | 159.94 |
Total Debt | 65.00 | 70.34 | 97.12 | 143.04 | 186.20 |
Other Liabilities | 10.01 | 7.87 | 8.89 | 6.65 | 8.31 |
Total Liabilities | 2,130.91 | 1,827.59 | 1,626.71 | 1,214.88 | 977.34 |
APPLICATION OF FUNDS : | |||||
Gross Block | 761.50 | 713.00 | 694.97 | 568.76 | 456.83 |
Less: Accumulated Depreciation | 237.96 | 200.98 | 160.77 | 127.60 | 100.09 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 523.54 | 512.02 | 534.20 | 441.16 | 356.74 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 179.08 | 164.81 | 29.99 | 96.32 | 101.71 |
Investments | 1,084.66 | 710.06 | 599.90 | 426.24 | 276.32 |
Current Assets, Loans & Advances | |||||
Inventories | 220.07 | 311.47 | 283.42 | 201.08 | 174.87 |
Sundry Debtors | 126.97 | 109.66 | 236.37 | 102.38 | 117.20 |
Cash and Bank Balance | 21.58 | 46.23 | 32.95 | 9.56 | 13.96 |
Loans and Advances | 73.48 | 94.91 | 75.00 | 71.07 | 54.83 |
Total Current Assets | 442.10 | 562.27 | 627.74 | 384.10 | 360.86 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 57.03 | 84.93 | 133.06 | 110.42 | 98.16 |
Provisions | 4.64 | 4.16 | 7.72 | 2.61 | 7.77 |
Total CL & Provisions | 61.68 | 89.10 | 140.78 | 113.03 | 105.93 |
Net Current Assets | 380.43 | 473.17 | 486.96 | 271.07 | 254.92 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 3.66 | 1.40 | 1.47 | 2.47 | 1.94 |
Deferred Tax Liability | 51.80 | 43.05 | 38.87 | 33.40 | 29.54 |
Net Deferred Tax | -48.14 | -41.65 | -37.40 | -30.93 | -27.60 |
Other Assets | 11.33 | 9.16 | 13.07 | 11.01 | 15.26 |
Total Assets | 2,130.90 | 1,827.58 | 1,626.72 | 1,214.87 | 977.35 |
Contingent Liabilities | 15.85 | 6.07 | 6.07 | 6.07 | 9.51 |